← Back to Clinical Trials
Recruiting NCT07217769

NCT07217769 Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07217769
Status Recruiting
Phase
Sponsor University of Pittsburgh
Condition Shift Work
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2026-05-01
Primary Completion 2030-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
No-nap15-min nap30-min nap

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 130 participants in total. It began in 2026-05-01 with a primary completion date of 2030-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Night shift work schedules disrupt sleep and have a negative impact on cardiovascular health. Most who work in public safety occupations and in healthcare work night shifts. These workers experience abnormal blood pressure during night shifts and are at greater risk of cardiovascular disease. Napping during night shifts can help to restore blood pressure patterns to a more normal pattern and may help to reduce risk of cardiovascular disease. Naps may also have an impact on alertness and performance immediately upon waking. The overarching goal of this study is to determine which duration of a nap taken during simulated night shift work has the greatest impact blood pressure and post-nap performance. Researchers will compare 5 nap durations to see which has the greatest impact on blood pressure patterns and post-nap psychomotor performance. Researchers hypothesize that longer naps will lead to improved blood pressure outcomes and shorter naps will contribute to better performance after waking. Findings will help employers and employees who work night shifts determine how best to incorporate brief naps during night shift work.

Eligibility Criteria

Inclusion Criteria: * non-pregnant adults (\>18 years of age) * certified public safety/healthcare shift worker * is an active shift worker * resides within the Western Pennsylvania region within reasonable driving distance Exclusion Criteria: * current use of medication for cardiovascular disease (e.g., hypertension) * prior or current diagnosis of sleep apnea, narcolepsy, restless leg syndrome, ischemic heart disease, heart failure, stroke, chronic kidney disease, chronic liver disease, rheumatologic disease requiring prescription medication, and cancer requiring treatment in past 2 years * undiagnosed severe sleep apnea (Apnea-Hypopnea Index \>30) based on at-home test * Abstains from caffeine or reports adverse effects from caffeine use

Contact & Investigator

Central Contact

Daniel Patterson, PhD

✉ pdp3@pitt.edu

📞 412-647-3078

Principal Investigator

Daniel Patterson

PRINCIPAL INVESTIGATOR

University of Pittsburgh

Frequently Asked Questions

Who can join the NCT07217769 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Shift Work. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07217769 currently recruiting?

Yes, NCT07217769 is actively recruiting participants. Contact the research team at pdp3@pitt.edu for enrollment information.

Where is the NCT07217769 trial being conducted?

This trial is being conducted at Pittsburgh, United States.

Who is sponsoring the NCT07217769 clinical trial?

NCT07217769 is sponsored by University of Pittsburgh. The principal investigator is Daniel Patterson at University of Pittsburgh. The trial plans to enroll 130 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology